Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies

里扎曲普坦 偏头痛 医学 安慰剂 子群分析 随机对照试验 月经 置信区间 麻醉 内科学 苏马曲普坦 病理 受体 替代医学 兴奋剂
作者
Vincent T. Martin,Roger Cady,Alexander Mauskop,Larry Seidman,Anthony Rodgers,Carolyn M. Hustad,Karen E. Ramsey,Franck Skobieranda
出处
期刊:Headache [Wiley]
卷期号:48 (2): 226-235 被引量:15
标识
DOI:10.1111/j.1526-4610.2007.00947.x
摘要

Objective.— A prospective subgroup analysis of the TAME (Treat A Migraine Early) studies examined the efficacy of rizatriptan in patients treating a menstrual migraine attack. Methods.— Both TAME studies were randomized, placebo‐controlled, and double‐blind. Adults with migraine were assigned (2:1) to either rizatriptan 10‐mg tablet or placebo. Patients were instructed to treat within 1 hour of migraine onset and when the pain was mild. The primary endpoint was 2‐hour pain freedom. The diagnosis of menstrual migraine was established according to the revised 2004 International Headache Society (IHS) diagnostic criteria. Data from both studies were pooled for logistic regression analyses. A test for interaction was performed to compare rates of 2‐hour pain freedom between patients treating a menstrual and non‐menstrual attack. Results.— A total of 94 patients (63 in the rizatriptan group and 31 in the placebo group) met IHS criteria for menstrual migraine and treated a menstrual attack. The percentage of patients reporting 2‐hour pain freedom was significantly greater for rizatriptan than for placebo (63.5% vs 29.0%; odds ratio = 4.5; 95% confidence interval: 1.7, 11.9; P = .002) in those treating a menstrual attack. In those treating with rizatriptan, the percentage of patients with 2‐hour pain freedom did not statistically differ between those treating a menstrual or non‐menstrual migraine attack (63.5% vs 57.5%; P = .454). Conclusion.— Rizatriptan 10 mg was effective for the treatment of menstrual migraine in an early intervention model, as measured by 2‐hour pain freedom. Rates of 2‐hour pain freedom were comparable for patients treating menstrual and non‐menstrual migraine attacks with rizatriptan.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
默默发布了新的文献求助10
刚刚
刚刚
酷波er的应助被DongLiang采纳,获得10
1秒前
1秒前
温柔樱桃发布了新的文献求助10
1秒前
1秒前
1秒前
双枪普朗克完成签到,获得积分10
1秒前
1秒前
Lucas的应助被张琳采纳,获得10
2秒前
彭佳乐完成签到,获得积分10
2秒前
Seasons发布了新的文献求助10
2秒前
3秒前
谎言不会伤人完成签到,获得积分10
3秒前
DPF做梦的乌龟完成签到,获得积分20
3秒前
小松弟完成签到,获得积分10
3秒前
3秒前
ding的应助被飘逸雨竹采纳,获得10
3秒前
3秒前
3秒前
MMM关闭了MMM的文献求助
4秒前
宋秋莲发布了新的文献求助10
4秒前
十一发布了新的文献求助10
4秒前
4秒前
Owen的应助被Shaelyn_Cheung采纳,获得10
4秒前
NexusExplorer的应助被feiyu采纳,获得10
4秒前
4秒前
6秒前
111发布了新的文献求助10
6秒前
狂炫砂糖柑完成签到,获得积分10
6秒前
Jay完成签到,获得积分10
7秒前
小二郎的应助被小p采纳,获得10
7秒前
英俊的铭的应助被宋城采纳,获得10
7秒前
王11发布了新的文献求助10
7秒前
初景发布了新的文献求助10
7秒前
英俊的铭的应助被林勇德采纳,获得10
7秒前
zzhs完成签到,获得积分10
8秒前
8秒前
秋风的应助被高贵碧凡采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170166
求助须知:如何正确求助?哪些是违规求助? 9563213
关于积分的说明 21768986
捐赠科研通 7761665
什么是DOI,文献DOI怎么找? 3430630
关于科研通互助平台的介绍 2554458
邀请新用户注册赠送积分活动 2475393